Drug Target in Eosinophilic Meningitis Caused by Angiostrongylus cantonensis

Title: Drug Target in Eosinophilic Meningitis Caused by Angiostrongylus cantonensis

Volume: 10 Issue: 5

Author(s): Kittisak Sawanyawisuth and Kanlayanee Sawanyawisuth

Affiliation:

Keywords: Angiostrongyliasis, Angiostrongylus cantonensis, cerebrospinal fluid, diagnosis, eosinophilic meningitis, snail, eosinophils, Gnathostoma spinigerum, Taenia solium, Baylisascaris procyonis, gnathostomiasis, baylisascariasis, Angiostrongylus costaricensis, EPIDEMIOLOGY, radiculomyelitis, EoM, EoE, PCR, immunoblotting, Meningoencephalitis, reibergrams, Corticosteroid, Anthelmintics, Prednisolone, mebendazole, albendazole, NSAIDs

Abstract: Eosinophilic meningitis caused by Angiostrongylus cantonensis is an emerging infectious disease. It is the most common form of human angiostrongyliasis. The diagnosis is made by clinical criteria including the presence of cerebrospinal fluid eosinophils and a history of exposure to A. cantonensis larvae, e.g., from raw freshwater snails or contaminated vegetables. Among various treatment options, corticosteroid is the only effective treatment.

Cite this article as:

Sawanyawisuth Kittisak and Sawanyawisuth Kanlayanee, Drug Target in Eosinophilic Meningitis Caused by Angiostrongylus cantonensis, Infectious Disorders - Drug Targets 2010; 10 (5) . https://dx.doi.org/10.2174/187152610793180867